| Old Articles: <Older 3721-3730 Newer> |
 |
The Motley Fool May 17, 2007 Brian Lawler |
MedImmune Gets the Thumbs-Up An advisory panel recommends expanded use for one of MedImmune's drugs.  |
The Motley Fool May 16, 2007 Rich Duprey |
Mylan's Costly Bid to Capture the Flag Its winning bid for a German Merck unit might be why it's falling behind in the generics game. Investors, take note.  |
The Motley Fool May 16, 2007 Mike Havrilla |
Nastech Nose Potential The small biotech reports the achievement of positive results for carbetocin nasal spray for the treatment of autism symptoms along with the completion of a $41 million stock offering in January.  |
The Motley Fool May 16, 2007 Mike Havrilla |
ZymoGenetics Is Poised to Stop Bleeding With shares of ZymoGenetics currently trading near three-year lows, now may be a good time to pick some up.  |
The Motley Fool May 16, 2007 Brian Lawler |
GPC's Next Cancer Drug? GPC Biotech prepares for its future as it awaits an FDA decision on its lead drug. Investors, take note.  |
The Motley Fool May 15, 2007 Brian Lawler |
King Fights for Its Empire King Pharmaceuticals announces another good quarter of financial results. Investors should expect more product acquisitions in the coming years.  |
The Motley Fool May 15, 2007 Mike Havrilla |
On the Threshold at Sonus The pharma is testing one drug that could be used to treat several types of cancer. Investors, take note.  |
The Motley Fool May 15, 2007 Rich Duprey |
Eisai Doles Out Tough Medicine The Japanese pharmaceutical company wins a patent infringement decision regarding its heartburn treatment. Investors, take note.  |
The Motley Fool May 15, 2007 Mike Havrilla |
A Heads-Up on TorreyPines The drugmaker's tezampanel for migraines shows promise after some trials. Investors, take note.  |
The Motley Fool May 15, 2007 Mike Havrilla |
Risky Bet OraSure Thing? The company strides forward to offer quick, less invasive methods of testing for disease and drugs. Investors, take note.  |
| <Older 3721-3730 Newer> Return to current articles. |